Precision medicine is moving toward a model where clinical, genomic, and imaging data must be integrated to deliver more accurate diagnoses and personalized treatments. Sasi Kumar Kolla, an artificial intelligence researcher, has recently published a study analyzing how foundation deep learning models can simultaneously process multiple data types —genomics, transcriptomics, radiology images, and electronic health records— overcoming the limitations of current systems that typically work with a single modality. His approach not only proposes a technical architecture but also addresses the infrastructure, governance, and bias challenges that must be resolved for these models to be viable in research and clinical settings.
Kolla’s work comes at a time when healthcare institutions generate massive volumes of heterogeneous information. However, most artificial intelligence systems in medicine remain specialized in a single data source: a pathology image, a genomic sequence, or a clinical report. This limits the ability to understand the complex biological interactions underlying diseases. As the researcher himself points out, 'biological processes rarely manifest in a single data type.' Hence, he proposes multimodal models that combine different representations within the same learning framework.
From a technical perspective, these models rely on self-attention mechanisms and contrastive learning, techniques proven effective in natural language processing and now adapted to align, for example, a medical image with its corresponding radiology report. Each modality is encoded separately and then fused into a shared representation layer, allowing the model to extract cross-relationships. This architecture resembles business intelligence systems that integrate multiple data sources to generate consolidated reports. In fact, BI tools like Power BI enable visualizing and correlating heterogeneous data, a necessary step for researchers to interpret the outputs of these foundation models.
One of the most notable aspects of Kolla’s study is the analysis of the required data infrastructure. Obtaining large, curated datasets with consistent standards remains a major bottleneck. Genomics, imaging, and clinical records are often stored in disparate formats with varying quality levels. To address this, the researcher proposes a coordinated data ecosystem that includes quality assurance processes, governance protocols, and privacy and consent mechanisms. This is where cloud capabilities come into play. Cloud services from AWS and Azure offer scalable and secure environments to store and process these large volumes of information, complying with regulations such as HIPAA or GDPR. Companies like Q2BSTUDIO, specialized in software development and cloud computing, help design these architectures, ensuring both scalability and the cybersecurity needed to handle sensitive patient data.
Cybersecurity is precisely another pillar that Kolla addresses in his work. Health data is one of the most coveted targets for cybercriminals, so any infrastructure managing it must include protection measures from the design stage. Multimodal models, by integrating information from multiple sources, increase the attack surface if adequate controls are not implemented. Therefore, the researcher insists that security and ethics must be central, not an afterthought. Technology companies offering cybersecurity and pentesting services play a fundamental role in validating these systems before deployment in clinical environments.
Another relevant challenge is data bias. Kolla notes that underrepresented populations in training datasets can produce models that perform worse for certain groups, a particularly serious risk in medicine. To mitigate this, he advocates for creating diverse and open datasets, as well as developing standardized evaluation protocols. In this regard, artificial intelligence agents —autonomous systems that can preprocess, clean, and balance data— are emerging as valuable helpers. These AI agents can, for example, identify imbalances in samples and suggest automatic adjustments, improving the fairness of the resulting models.
Interpretability is equally crucial. A model that provides an accurate prediction but does not explain how it arrived at it generates distrust among doctors and researchers. Kolla proposes that transparency should be as important as accuracy. Publishing model weights, sharing reference datasets, and establishing open benchmarks are practices that foster reproducibility and independent scrutiny. Visualization and BI tools, such as Power BI dashboards, can help clinicians understand the variables that most influence a prediction, bridging the gap between the model’s black box and clinical decision-making.
Regarding concrete applications, Kolla’s study mentions the integration of genomic and transcriptomic data to study gene expression patterns, as well as the combination of radiology images with radiomics data for multi-organ research. It also explores hypergraph-based methods to model relationships between biological samples and clinical conditions. These use cases require custom software development that adapts multimodal architectures to the specific needs of each domain. Custom software applications enable the implementation of everything from preprocessing pipelines to user interfaces that facilitate interaction with these complex models.
The path toward multimodal foundation models for precision medicine is still incipient, but works like Sasi Kumar Kolla’s lay out a clear roadmap. Advances are needed in data infrastructure, governance, interpretability, and above all, interdisciplinary collaboration. Technology companies, particularly those with expertise in cloud, cybersecurity, artificial intelligence, and custom software development, are natural allies in this process. Q2BSTUDIO, with its portfolio of services ranging from custom software to cloud AWS/Azure, BI/Power BI, and AI agents, positions itself as a partner capable of building the infrastructure these models demand.
Ultimately, Kolla’s research not only sheds light on a complex technical problem but also invites the entire community —researchers, clinicians, engineers, and companies— to work together so that multimodal artificial intelligence becomes a practical and ethical reality in the medicine of the future.
